HYBRITECH TANDEM PSA TEST APPROVED AS DIAGNOSTIC AID
This article was originally published in The Gray Sheet
Executive Summary
HYBRITECH TANDEM PSA TEST APPROVED AS DIAGNOSTIC AID in the detection of prostate cancer. The Tandem-R (immunoradiometric), Tandem-E (immunoenzymetric) and Tandem-ERA (automated enzyme immunoassay) assays for quantitative prostate specific antigen measurement become the first PSA blood tests approved for use in detecting the disease.